FDA 21 CFR Part 820 (QSR) Consultant in Mumbai
The medical device industry in Mumbai is rapidly growing, with a significant presence of domestic and international players. Industry is closely connected with 21 CFR(QSR) to access new medical devices in US market.
FDA 21 CFR Part 820 medical device covers the processes used in the facilities & controls used for the design, manufacture, packaging, labeling, storage, installation & servicing of medical devices. The industry covers a wide range of products, including implantable devices, diagnostic equipment, surgical instruments, and more. With a rapidly growing demand for medical devices in India, and as Mumbai is the largest industrial and commercial center of India, the medical device industry in Mumbai is well-positioned for continued growth and success.
What is FDA 21 CFR Part 820?
21 CFR Part 820, also known as the Quality System Regulation (QSR), is a set of regulations established by the US Food and Drug Administration (FDA) that outlines the requirements for medical device manufacturers to establish and maintain a quality management system (QMS). The QSR applies to all medical devices sold in the United States, regardless of whether they are manufactured domestically or imported.
Looking for Consultant in Mumbai?
Let’s have word about your project
This process typically involves a team of experts, including engineers, scientists, regulatory specialists, and quality assurance professionals, who work together to ensure that the medical device is safe, effective, and meets the needs of patients and healthcare providers.
How Operon Strategist can assist in FDA 21 CFR Part 820(QSR) in Mumbai?
Role in FDA 21 CFR Part 820 – Quality System Regulations:
- Operon Strategist does an initial gap analysis of the existing system to determine the extent of development of the quality system.
- Provide 21 CFR 820 training courses in which we guide the clients through documentation & help them to effectively implement it through the various functions of the company.
- Conducted a mock audit to test the effectiveness of the implementation of Part 820 requirements.
- Provide post-inspection guidance to clients to help them close any non-conformance observed during the audit.
- FDA 21 CFR Part 820 helps manufacturers to build and follow quality systems to help assure that their products consistently meet applicable requirements and specifications.
FAQs
What is FDA 21 CFR Part 820?
FDA 21 CFR Part 820, also known as the Quality System Regulation (QSR), is a regulation issued by the U.S. Food and Drug Administration that defines Quality Management System (QMS) requirements for medical device manufacturers selling products in the United States.
Who must comply with 21 CFR Part 820?
All medical device manufacturers marketing devices in the US—whether domestic or international—must comply with FDA 21 CFR Part 820 requirements.
What does 21 CFR Part 820 cover?
It covers design controls, production and process controls, packaging, labeling, storage, installation, servicing, CAPA (Corrective and Preventive Action), complaint handling, and documentation requirements.
Why is 21 CFR Part 820 important for Mumbai-based manufacturers?
Compliance enables Mumbai-based manufacturers to legally access the US market, improve product quality, minimize regulatory risks, and enhance global credibility.
Is FDA 21 CFR Part 820 mandatory for exporting medical devices to the US?
Yes. Compliance with 21 CFR Part 820 is mandatory for all manufacturers who intend to sell or distribute medical devices in the United States.